No images? Click here
21 November 2022
WHO has launched a new strategy to respond to the urgent problem of antimalarial drug resistance in Africa. The strategy was released during World Antimicrobial Awareness Week, a global annual campaign to improve awareness of the growing threat of resistance to antibiotics and other medicines.
New WHO strategy | WHO news release | Q&A on artemisinin resistance | World Antimicrobial Awareness Week
Experts share insights on drug resistance in Africa
What is causing antimalarial drug resistance to spread in Africa? And why does the issue demand attention now? We spoke with 2 experts on this topic: Dr Dorothy Achu, WHO’s new Team Lead for Tropical Vector Borne Diseases in the Regional Office for Africa, and Dr Marian Warsame, who has researched the issue extensively in Africa and the Eastern Mediterranean regions.
Interview with Dr Dorothy Achu | Interview with Dr Marian Warsame
By 2050, nearly 7 out of 10 people globally will live in cities and other urban settings. While urbanization overall is expected to reduce malaria transmission, unplanned urbanization will likely result in a malaria disease burden that is disproportionately high among the urban poor. A new framework from WHO and UN-Habitat offers guidance to city leaders, health programmers and urban planners as they respond to the challenges of a rapidly urbanizing world.
New global framework from WHO and UN-Habitat | Q&A with Dr Abdisalan Noor, lead author the framework | News release issued on World Cities Day
WHO’s malaria guidance can be accessed through several new digital platforms: MAGICapp, a mobile app and animated videos. By responding to this survey, you can help us determine whether these platforms are meeting your needs.
New resources on G6PD and malaria diagnosis
The Global Malaria Programme has released two new resources on glucose-6-phosphate dehydrogenase (G6PD) and malaria diagnosis:
- Two target product profiles describing the characteristics of new types of diagnostics to measure G6PD activity.
- A new guide defining requirements for quality and safety for malaria rapid diagnostic testing services.
The WHO response plan to pfhrp2 deletions calls for urgent action to determine the scale and scope of the problem. WHO has developed a dashboard to generate a global picture of pfhrp2/3 surveillance efforts and is calling on all partners to contribute.
